Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment

por van Maldegem, Annemiek M, Bhosale, Aparna, Gelderblom, Hans J, Hogendoorn, Pancras CW, Hassan, Andrew B
Publicado 2012

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer

por Zunder, Stéphanie M., van Pelt, Gabi W., Gelderblom, Hans J., Mancao, Christoph, Putter, Hein, Tollenaar, Rob A., Mesker, Wilma E.
Publicado 2018